Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Cash from Operations (2021 - 2023)

Updated

Nika Pharmaceuticals (NIKA) recorded Cash from Operations of $10,143 in Q3 2023, up 29.4% from $7,839 a year earlier but down 84.8% from the prior quarter.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Cash from Operations (2021 - 2023) Analysis & Trends

On a TTM basis, Nika Pharmaceuticals' Cash from Operations came in at $72,569 as of Sep 30, 2023, up 62.0% year-over-year; for FY2022, it came in at $33,715, up 129.2% from FY2021.

  • Across earlier years, Cash from Operations came in at $14,712 in FY2021.
  • Quarterly Cash from Operations has ranged from -$19,570 in Q1 2023 to $66,946 in Q2 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $66,946 (Q2 2023), -$19,570 (Q1 2023) and $15,050 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 10,143.00
Jun 30, 2023 66,946.00
Mar 31, 2023 -19,570.00
Dec 31, 2022 15,050.00
Sep 30, 2022 7,839.00
Jun 30, 2022 17,142.00
Mar 31, 2022 -6,316.00
Dec 31, 2021 26,124.00
Sep 30, 2021 -2,699.00
Jun 30, 2021 -2,959.00
Mar 31, 2021 -5,754.00
API Access

Nika Pharmaceuticals, Inc Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NIKA&period=max&api_key=YOUR_API_KEY